Drugs / PEP03
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00219648 | Sep 2004 → ? | chronic obstructive pulmonary disease | PharmaEngine | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PEP03 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00219648 ↗ |
| Action | Inhibit | “PEP03 exerts its action by blocking the generation of both cysteinyl LTs and LTB4.” NCT00219648 ↗ |
| Modality | Small molecule | “PEP03 is a new chemical entity” NCT00219648 ↗ |
| Route | Oral | “orally active” NCT00219648 ↗ |